Skip to main content
TASCOM Co.,Ltd. logo

TASCOM Co.,Ltd. — Investor Relations & Filings

Ticker · 336040 ISIN · KR7336040001 KO Manufacturing
Open in API
Filings indexed 189 across all filing types
Latest filing 2021-03-23 Declaration of Voting R…
Country KR South Korea
Listing KO 336040

About TASCOM Co.,Ltd.

http://tascom.org/

TASCOM Co., Ltd. is a company that develops, manufactures, and distributes medical devices, specializing in in vitro diagnostics (IVD) and diabetes management. Its key product is the SimplexTAS series, a point-of-care testing (POCT) immunochemistry system that functions as a portable analyzer for quantitative, multi-parameter biochemical immunoassays using small blood or urine samples. The company's portfolio also includes a range of diabetic supplies, such as blood glucose measurement systems and insulin syringes. Additionally, TASCOM is engaged in the research and development of cell therapy products.

Recent filings

Filing Released Lang Actions
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled '정기주주총회 결과' (Annual General Meeting Results) and details the outcomes of the shareholder meeting held on 2021-03-23, including the approval of financial statements, director/auditor compensation limits, and dividend status. This falls directly under the category of Declaration of Voting Results & Voting Rights Announcements.
2021-03-23 Korean
사업보고서 (2020.12)
Audit Report / Information Classification · 1% confidence The document is a comprehensive 'Audit Report' (감사보고서) for '주식회사 이도바이오' (IdoBio Co., Ltd.) for the fiscal year 2020. It includes the independent auditor's report, financial statements (balance sheet, income statement, statement of changes in equity, cash flow statement), and detailed notes to the financial statements. It is not an Annual Report (10-K) as it lacks the broader management discussion and analysis typical of a full annual report, and it is not an Earnings Release (ER) as it is a full audited financial package. FY 2020
2021-03-15 Korean
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a short regulatory filing titled '감사보고서 제출' (Submission of Audit Report) which provides a summary table of audit opinions and key financial figures (assets, liabilities, revenue, etc.) for the company '이도바이오'. It is a standard regulatory disclosure announcing the submission of the audit report to the exchange, rather than the full audit report document itself. Given the short length and the nature of the disclosure, it fits the 'Report Publication Announcement' (RPA) category. FY 2020
2021-03-08 Korean
주주총회소집공고
AGM Information Classification · 1% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for 'Yido Bio Co., Ltd.' (주식회사 이도바이오). It contains the meeting date, location, agenda items (financial statements, director/auditor compensation), and management information regarding the company's business status and industry outlook. This document is a formal notice sent to shareholders to provide information and request votes for the upcoming Annual General Meeting. According to the provided definitions, this fits the 'Proxy Solicitation & Information Statement' (PSI) category, as it serves to inform shareholders and solicit their participation/votes for the meeting.
2021-03-05 Korean
주주총회소집결의
AGM Information Classification · 1% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집 결의) for IdoBio, detailing the date, location, and agenda items such as financial statement approval and director remuneration. This type of document is sent to shareholders to provide information and request votes for an upcoming meeting, which aligns perfectly with the definition of a Proxy Solicitation & Information Statement.
2021-02-19 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and their special relations, including acquisition methods, funding sources, and changes in shareholding percentages. This falls under the category of Major Shareholding Notification.
2021-02-18 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.